www.fdanews.com/articles/176672-india-caps-prices-for-54-drugs
India’s pricing authority is capping prices for 54 drug formulations, including products used to treat seizures, rheumatoid arthritis and bacterial infections.
The National Pharmaceutical Pricing Authority’s latest price ceiling notice includes 13 revisions to prior caps and 41 new restrictions.